Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Citra Borneo Utama Tbk. (CBUT) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Citra Borneo Utama Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Citra Borneo Utama Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Citra Borneo Utama Tbk. trades at Rp790 (market cap 2.48T, 18.1K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.14M 24h volume). The key difference: Citra Borneo Utama Tbk. is far larger — about 4.3× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.14M versus 18.1K). Which is the better fit depends on your goals.

CBUTLABS
Market Cap
2.48T576.7B
Volume
18.1K3.14M
Lot
18131.39K
Turnover
14.42M472.14M
Average Price
796.8150.43
Value
14.42M472.14M
Indicative Equilibrium Price
810147
Indicative Equilibrium Volume
24311

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CBUT
View details
LABS
View details

About Citra Borneo Utama Tbk.

PT Citra Borneo Utama Tbk (the “Company”) was established based on Notarial Deed No. 102 dated 14 March 2013 of Teguh Hendrawan, S.H., M.Kn. Notary in Pangkalan Bun. The Company commenced its commercial activities in August 2018.

Read more on CBUT

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS